6
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Radiosensitization of HL-60 human leukaemia cells by bryostatin-1 in the absence of increased DNA fragmentation or apoptotic cell death

, , , &
Pages 183-192 | Published online: 03 Jul 2009

References

  • AGAKI, y., IT0, K. and SAWADA, S., 1993, Radiation-induced apoptosis and necrosis in Molt-4 cells: a study of dose—effect relationships and their modification. Inter-nationalJournal of Radiation Biology, 64, 47–56.
  • BASU, A., and LAzo, J. S., 1992, Sensitization of human cervical carcinoma cells to cis-diamminedichloroplatinum (II) by bryostatin 1. Cancer Research, 52, 3119–3124.
  • BERKOW, R., and KRAFT, A., 1985, Bryostatin, a non-phorbol macrocyclic lactone, activates intact human poly-morphonuclear leucocytes and binds to the phorbol receptor. Biochimica et Biophysica Acta, 131, 1109–1116.
  • CHAMPLIN, R., and GALE, R. P., 1987, Bone marrow transplanta-tion for acute leukemia; recent advances and compar-isons with alternative therapies. Seminars in Hematology, 24, 55–67.
  • FORNARI, F. A., RANDOLPH, J. K., YALOWICH, J. C., RITKE, M. K., and GEWIRTZ, D. A., 1994, Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells. Molecular Pharmacology, 45, 649–656.
  • FuKs, Z., PERSAUD, R. S., ALFIERI, A., MCLOUGHLIN, M., EHLEITER, D., SCHWARTZ, J. L., SEDDON, A. P., CORDON-CARDO, C., and HAIMOVITZ-FRIEDMAN, A., 1994, Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. Cancer Research, 54, 2582–2590.
  • GALLEGHER, R., COLLINS, S., TRUJILLO, J., MCCREDIE, K., AHEARN, M., TSAI, S., METZGER, R., AULUKH, G., TING, R., RUSCETTI, F. and GALLO, R., 1979, Characterization of the contin-uous differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood, 54, 713–733.
  • GRANT, S., JARVIS, D., SWERDLOW, P., TURNER, A., TRAYLOR, R., WALLACE, H., LIN, P.-S., PETTIT, G. R., and GEWIRTZ, D. A., 1992b, Potentiation of the activity of 143-D arabinofur-anosylcytosine by the macrocyclic lactone PK-C activator bryostatin 1 is associated with enhanced fragmentation of mature DNA. Cancer Research, 52, 6270–6278.
  • GRANT, S., PETTIT, G. R., HowE, C., and MCCRADY, C., 1991, Effect of the PKC activating agent bryostatin 1 on the clonogenic response of leukemic blast progenitors to recombinant granulocyte-macrophage colony stimu-lating factor. Leukemia, 5, 392–398.
  • GRANT, S., PETTIT, G. R., and MCCRADY, C., 1992a, Effect of the PK-C activator bryostatin 1 on the in vitro radio-protective effects of recombinant granulocyte-macro-phage colony stimulating factor (rGM-CSF) toward normal human myeloid progenitor cells (CFU-GM). Experimental Hematology, 20, 34–42.
  • GRANT, S., TRAYLOR, R., PETTIT, G. R., and LIN, P.-S., 1993, Lineage-specific potentiation of the in vitro radiopro-tective effects of the GM-CSF/IL-3 fusion protein PIXY 321 toward normal human bone marrow progenitors by bryostatin 1. Cytokine, 5, 490–497.
  • GRANT, S., TRAYLOR, R., PETTIT, G. R., and LIN, P.-S., 1994a, In vivo radioprotective effects of the PK-C activator bryos-tatin 1, either alone, or in conjunction rmGM-CSF in C3H/HeN and Balb/c mice. Blood, 83, 663–667.
  • GRANT, S., TURNER, A., BARTIMOLE, T., JOE, V., and JARvis, D., 1994b, Modulation of 143-o arabinofuranosylcytosine-induced apoptosis in human promyelocytic leukemia cells by staurosporine and other inhibitors of protein kinase C. Oncology Research, 6, 87–99.
  • HAIMOVITZ-FRIEDMAN, A., BALABAN, N., MCLOUGHLIN, M., EHLEITER, D., MICHAELI, J., VLODAVSKY, I., and FuKs, Z., 1994, Protein kinase C mediates basic fibroblast growth factor pro-tection of endothelial cells against radiation-induced apoptosis. Cancer Research, 54, 2591–2597.
  • HALLAHAN, D. E., VIRUDACHALAM, S., GRDINA, D., and WEICHSEL-BAUM, R. R., 1992a, The isoquinoline, Sulfonamide H7 attenuates radiation-mediated protein kinase C activa-tion and delays the onset of x-ray induced G2 arrest. International Journal of Radiation Oncology, Biology and Physics, 24, 687–692.
  • HALLAHAN, D. E., VIRUDACHALAM, S., SCHWARTZ, J. L., PANJE, N., MUSTAFI, R., and WEICHSELBAUM, R. R., 1992b, Inhibition of protein kinase sensitizes human tumor cells to ionizing radiation. Radiation Research, 129, 345–350.
  • HALLAHAN, D. E., VIRUDACHALAM, S., SHERMAN, M. L., HUBERMAN, E., KUFE, D. W., and WEICHSELBAUM, R. R., 1991, Tumor necrosis factor gene expression is mediated by protein kinase C following activation by ionizing radiation. Cancer Research, 51, 4565–4569.
  • IsAKov, N., GALRON, H., MUSTELIN, T., PETTIT, G. R., and ALTMAN, A., 1993, Inhibition of phorbol ester induced T-cell proliferation by bryostatin is associated with rapid degradation of protein kinase C. Journal of Immunology, 150, 1195–1204.
  • JARws, W. D., FORNARI, F. A., KOLESNICK, R. N., BROWNING, J. L., GEwnurz, D. A., KOLESNICK, R. N., and GRANT, S., 1994c, Attenuation of ceramide-induced apoptosis by digly-ceride in human myeloid leukemia cells by diglyceride. Journal of Biological Chemistry, 269, 31685–31692.
  • JARws, W. D., GEWIRTZ, D. A., POVIRK, L., TURNER, A., TRAYLOR, R., PETTIT, G. R., and GRANT, S., 1994a, Effect of bryostatin 1 and other activators of protein kinase C on 14/3-D-arabinofuranosyl-lcytosine-induced apoptosis in HL-60 human promyelocytic leukemia cells. Biochemical Pharmacology, 47, 839–852.
  • JARws, D. W., KOLESNICK, R. W., FORNARI, F. A., TRAYLOR, R. S., GEWIRTZ, D. A., and GRANT, S., 1994d, Activation of the sphingomyelin pathway initiates apoptosis in a variety of mammalian cell lines. Proceedings of the National Academy of Sciences, USA, 91, 73–77.
  • JARws, H., POVIRK, L., TURNER, A., TRAYLOR, R., and GRANT, S., 1994b, Induction of DNA fragmentation and cell death in (HL-60) human promyelocytic leukemia cells by pharmacologic inhibitors of protein kinase C. Cancer Research, 54, 1707–1714.
  • JIANG, H., LIA, J., SU, Z., COLLART, F. R., HABERMAN, E., and FISHER, P. B., 1994, Induction of differentiation of human promyleocytic leukemic cells activates p21 wafl/cipl in the absence of p53. Oncogene, 9, 3397–3406.
  • JONES, R., SHARKIS, S., MILLER, C., ROWINSKI, E., BURKE, P., and MAY, W., 1990, Bryostatin 1, a unique biological modifier: anti-leukemic activity in vitro. Blood, 75, 1319–1323.
  • KALECHMAN, Y, ALBECK, M., and TREDNI, B., 1992, /n vivo synergistic effect of the immunomodulator AS101 and the PKC inducer bryostatin. Cellular Immunology, 143, 143–153.
  • KHARABNDA, S., DATTA, R., and KUFE, D., 1991, Regulation of c-jun gene expression in HL-60 leukemia cells by 1-E-arabinofuranosylcytosine. 1991. Potential involvement of a protein kinase C dependent mechanism. Biochemistry, 30, 7947–7952.
  • KISS, Z., DELI, E., GIRARD, p., PETTIT, G., and Kuo, J., 1987, Comparative effects of polymyxin B, phorbol ester and bryostatin on protein phosphorylation, protein kinase C translocation, phospholipid metabolism and differ-entiation of HL60 cells. Biochemical and Biophysical Research Communications, 146, 208–215.
  • LANGLEY, R. E., PALAYOOR, S. T., COLEMAN, C. N., and BUMP, E. A., 1994, Radiation-induced apoptosis in F9 teratocarci-noma cells. International Journal of Radiation Biology, 65, 605–610.
  • LOTEM, J., GRAGOE, E., and SACHS, L., 1992, Rescue from programmed cell death in leukemic and normal cells. Blood, 79, 953–960.
  • MAY, W., SHARKIS, S., ESA, A., GEBBIA, V., KRAFT, A., PETTIT, G., and SENSENBRENNER, L., 1987, Antineoplastic bryostatins are multipotent stimulators of human hematopoietic pro-genitor cells. Proceedings of the National Academy of Sciences, USA, 84, 8483–8487.
  • McCoNKEE, D. J., HARTWELL, p., JONDAL, M., and ORRENIU SS., 1989, Inhibition of DNA fragmentation in thymocytes and isolated thymocyte nuclei by agents that stimulate protein kinase C. Journal of Biological Chemistry, 264, 13399–13402.
  • McCoNKEE, D. J., and ORRENIU SS., 1994, Signal transduction pathways to apoptosis. Trends in Cell Biology, 4, 370–374.
  • NISHIZUKA, Y, 1992, Intracellular signalling by hydrolysis of phospholipids and activation of protein kinase C. Science, 258, 607–614.
  • OJEDA, F., GICARDA, M. I., MALDONALD, C., and FOLCH, N., 1990, Protein kinase C involvement in thymocyte apoptosis by hydrocortisone. Cellular Immunology, 125, 535–539.
  • RADFORD, I. R., 1994, Phorbol esters can protect mouse pre-T cell lines from radiation-induced rapid interphase apoptosis. International Journal of Radiation Biology, 65, 345–355.
  • RADFORD, I. R., and MURPHY, T. K., 1994, Radiation response of mouse lymphoid and myeloid cell lines Part III. Dif-ferent signals can lead to apoptosis and may influence sensitivity to killing by DNA double-strand breaks. International Journal of Radiation Biology, 65, 229–239.
  • RADFORD, I. R., MURPHY, T. K., RADLEY, J. M., and ELLIS, S. L., 1994, Radiation response of mouse lymphoid and myeloid cells Part II. Apoptotic death is shown in all lines examined. InternationalJournal of Radiation Biology, 65, 217–227.
  • STEPHENS, L. C., HUNTER, N. R., ANG, K. K., MILAS, L., and MEYN, R. E., 1993, Development of apoptosis in irradiated murine tumors as a function of time and dose. Radia-tion Research, 135, 75–80.
  • TOMEI, L. D., KANTER, P., and WENNER, C. E., 1988, Inhibition of radiation-induced apoptosis in vitro by tumor promoters. Biochemical and Biophysical Research Communications, 155, 324–331.
  • XU, H-M., TEPPER, C. G., JONES, J. B., FERNANDEZ, C. E., and STUDZINSKI, G. P., 1993, 1,25-Dihydroxyvitamin D3 pro-tects HL-60 cells against apoptosis but down-regulates the expression of the bcl-2 gene. Experimental Cell Research, 209, 367–374.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.